Key facts
| Firm | Alvotech Hf |
|---|---|
| FEI / inspection ID | 3013702557 |
| Inspection end date | May 8, 2026 |
| Citation count | 1 |
What a Form 483 means
A Form FDA 483 is issued at the close of an FDA facility inspection to list conditions an investigator observed that may violate the Federal Food, Drug, and Cosmetic Act or its implementing regulations. It reflects the investigator's professional judgment at that point in time and is not a final agency determination, an enforcement action, or proof that a violation occurred. Firms are expected to respond in writing, typically within 15 business days, describing the corrective and preventive actions they plan to take. FDA reviews that response, along with any follow-up evidence, before deciding what happens next. Many 483s are resolved through corrective action alone. When FDA judges a firm's response inadequate, or when the underlying conditions are serious enough, the observations documented here can lead to a Warning Letter or further regulatory action. This page presents the observations exactly as recorded on the FDA-issued document; always confirm citation language against the original record before relying on it.
Citations explained
Observation 1 — -- 1 of 7 -- -- 2 of 7 -- -- 3 of 7 -- -- 4 of 7 -- -- 5 of 7 -- -- 6 of 7 -- -- 7 of 7
-- 1 of 7 -- -- 2 of 7 -- -- 3 of 7 -- -- 4 of 7 -- -- 5 of 7 -- -- 6 of 7 -- -- 7 of 7 -- A Form FDA 483 is issued at the close of an FDA facility inspection to list conditions an investigator observed that may violate the Federal Food, Drug, and Cosmetic Act or its implementing regulations. It reflects the investigator's professional judgment at that point in time and is not a final agency determination, an enforcement action, or proof that a violation occurred. Firms are expected to respond in writing, typically within 15 business days, describing the corrective and preventive actions they plan to take. FDA reviews that response, along with any follow-up evidence, before deciding what happens next. Many 483s are resolved through corrective action alone. When FDA judges a firm's response inadequate, or when the underlying conditions are serious enough, the observations documented here can lead to a Warning Letter or further regulatory action. This page presents the observations exactly as recorded on the FDA-issued document; always confirm citation language against the original record before relying on it. A Form FDA 483 is issued at the close of an FDA facility inspection to list conditions an investigator observed that may violate the Federal Food, Drug, and Cosmetic Act or its implementing regulations. It reflects the investigator's professional judgment at that point in time and is not a final agency determination, an enforcement action, or proof that a violation occurred. Firms are expected to respond in writing, typically within 15 business days, describing the corrective and preventive actions they plan to take. FDA reviews that response, along with any follow-up evidence, before deciding what happens next. Many 483s are resolved through corrective action alone. When FDA judges a firm's response inadequate, or when the underlying conditions are serious enough, the observations documented here can lead to a Warning Letter or further regulatory action. This page presents the observations exactly as recorded on the FDA-issued document; always confirm citation language against the original record before relying on it.
Alvotech Hf’s FDA history
Argus HQ has recorded 2 total FDA actions tied to Alvotech Hf: 0 warning letters, 0 recalls, 0 approval records, and 2 Form 483 inspection citations.
Frequently asked questions
- Has Alvotech Hf had other FDA inspection citations?
- Yes. Argus HQ has recorded 2 total FDA actions tied to Alvotech Hf, including 2 Form 483 inspection citations.
- What is the FEI / inspection ID for this Form 483?
- FEI / inspection ID: 3013702557.
- Is a Form 483 the same as a Warning Letter?
- No. A Form 483 lists an FDA investigator’s observations at the close of an inspection; it is not a final agency determination. FDA may or may not follow up with a Warning Letter depending on the firm’s response and the severity of the findings.
- Where can I read the full Form 483?
- The verbatim inspection record is the source of truth — always confirm citation language against the original FDA document before acting.
See if this 483 escalates to a warning letter — before your auditor asks.
Free weekly briefing tracks every FDA inspection outcome.
Related enforcement actions
Full FDA history for Alvotech Hf- 483 inspection (recent): Strides Pharma Science Limited -- FDA 483: 1 observation (2026-05-20) →
- 483 inspection (recent): Mixlab WI LLC -- FDA 483: 1 observation (2026-05-01) →
- 483 inspection (recent): Sincerus Florida, LLC -- FDA 483: 5 observations (2026-05-29) →
- 483 inspection (recent): Lt Col Luke Weather Jr Veterans Affairs Medical Center -- FDA 483: 6 observations (2026-06-04) →
- 483 inspection (recent): Denver Solutions LLC dba Leiters Health -- FDA 483: 1 observation (2026-06-08) →
- 483 inspection (recent): Annovex Pharma Inc -- FDA 483: 1 observation (2026-07-03) →
- 483 inspection (recent): Turbare Manufacturing -- FDA 483: 4 observations (2026-07-07) →
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). FDA Inspects Alvotech Hf: Form 483 with 1 Citations (May 8, 2026). Digital Empire Holdings LLC. Retrieved from https://argushq.ai/483/alvotech-hf-3013702557-2026-05-08
"FDA Inspects Alvotech Hf: Form 483 with 1 Citations (May 8, 2026)." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/483/alvotech-hf-3013702557-2026-05-08.
Argus HQ Research. "FDA Inspects Alvotech Hf: Form 483 with 1 Citations (May 8, 2026)." Digital Empire Holdings LLC. Accessed July 29, 2026. https://argushq.ai/483/alvotech-hf-3013702557-2026-05-08.
@misc{argushq_argushq_ai_483_alvotech_hf_3013702557_2026_05_08_2026,
title = {FDA Inspects Alvotech Hf: Form 483 with 1 Citations (May 8, 2026)},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/483/alvotech-hf-3013702557-2026-05-08},
note = {Accessed: July 29, 2026}
}
